CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 44 enrolled
Drug / intervention
MBB AFO +1 moredevice
Likely dose
Not stated in record
Key inclusion· 3
  • Age 65 years or older
  • High concerns or high risk of fall
  • Ambulatory
Key exclusion· 7
  • Active wound infection on foot or ankle
  • Medication or medical condition causing unstable or temporary (less than one month) changes to gait and balance
  • Acute fractures on the foot
  • Participant in another interventional study within last 30 days

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02819011
NCT02819011Phase 2Completed

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Bijan Najafi, PhD·interventional·Posted Jun 30, 2016·Updated Feb 27, 2020

In Brief

A Phase 2 clinical trial evaluating MBB AFO and Control for Accidental Falls and 8 related conditions. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The investigators propose a randomized control trial to evaluate long term effects and effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of falling in older adults. Primary Endpoints • Characterize the impact of MBB AFO on balance, gait, risk of falling, frailty status, and adverse events Secondary Endpoints • Characterize the Impact of MBB AFO on spontaneous daily physical activities • Characterize the feasibility of the MBB AFO device on patient adherence, acceptability, user-friendliness, and perception of benefit for daily usage

Study Details

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJun 30, 2016
Enrollment StartMay 1, 2016
Primary CompletionDec 1, 2018
Study CompletionApr 4, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 10.0 years ago

Interventions

MBB AFOdevice

Subjects will be provided with a pair of New Balance 813 shoes plus a custom made MBB AFO

Controlother

Subjects will be provided with a pair of New Balance 813 shoes